SART3 anticorps (N-Term)
-
- Antigène Voir toutes SART3 Anticorps
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Épitope
- N-Term
-
Reactivité
- Humain, Rat, Cobaye, Chien, Cheval, Porc
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SART3 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- TSASEPEAES KAGPKADGEE DEVKAARTRR KVLSRAVAAA TYKTMGPAWD
- Homologie
- Dog: 77%, Guinea Pig: 79%, Horse: 79%, Human: 100%, Pig: 86%, Rat: 79%
- Attributs du produit
- This is a rabbit polyclonal antibody against SART3. It was validated on Western Blot and immunohistochemistry.
- Purification
- Protein A purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human SART3
- Top Product
- Discover our top product SART3 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 364 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma." dans: PLoS ONE, Vol. 12, Issue 1, pp. e0170291, (2017) (PubMed).
: "
-
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma." dans: PLoS ONE, Vol. 12, Issue 1, pp. e0170291, (2017) (PubMed).
-
- Antigène
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Autre désignation
- SART3 (SART3 Produits)
- Synonymes
- anticorps SART3, anticorps DKFZp469J2418, anticorps si:ch211-191d15.4, anticorps wu:fc51h03, anticorps DSAP1, anticorps P100, anticorps RP11-13G14, anticorps TIP110, anticorps p110, anticorps p110(nrb), anticorps AU045857, anticorps mKIAA0156, anticorps squamous cell carcinoma antigen recognized by T-cells 3, anticorps squamous cell carcinoma antigen recognized by T-cells 3 L homeolog, anticorps squamous cell carcinoma antigen recognized by T cells 3, anticorps SART3, anticorps sart3, anticorps sart3.L, anticorps Sart3
- Sujet
-
SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
Alias Symbols: P100, p110, DSAP1, TIP110, p110(nrb), RP11-13G14
Protein Interaction Partner: APBB1, PRPF3, Usp15, AMOT, SF3B1, NUP160, LRPPRC, THRAP3, BCLAF1, VARS, UBC, SUMO2, RAB1A, NEFM, IARS, HIF1A, DSG2, DHX9, MEPCE, HIST2H2BE, HIST2H2AC, RNF2, BMI1, RUFY1, NRBP1, PSME4, AKAP2, COPS5, NUP50, POP7, ARHGEF10, PSMB3, PSMA5, PSMA3, POLR2H, CAST,
Protein Size: 364 - Poids moléculaire
- 40 kDa
- ID gène
- 9733
- NCBI Accession
- NM_014706
- Pathways
- Ribonucleoprotein Complex Subunit Organization
-